Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab […]
Continue reading »